Condition
Microsatellite Instability-High Colorectal Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Microsatellite Instability-High Colorectal Cancer clinical trials that are recruiting, at sites in 4 countries (most in United States (2), France (1), Australia (1)). By phase: Phase 1/2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 4Countries
Newest Microsatellite Instability-High Colorectal Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Active surveillance after immunotherapy for MMR-deficient colorectal and GI cancers | — | Basel and 2 other locations | Recruiting | Sep 18, 2026 |
| Evaluating biomarkers for immunotherapy resistance in metastatic colorectal cancer | — | Bayonne and 19 other locations | Recruiting | Apr 9, 2024 |
| Testing NEO212 for treating certain brain tumors and metastases | Phase 1/2 | Beverly Hills, California and 7 other locations | Recruiting | Sep 21, 2023 |
| FOG-001 treatment for advanced or metastatic solid tumors | Phase 1/2 | Phoenix, Arizona and 32 other locations | Recruiting | Jun 26, 2023 |
All recruiting trials (4)
-
Active surveillance after immunotherapy for MMR-deficient colorectal and GI cancers
This study looks at whether some patients with non-metastatic, MMR-deficient or MSI-H colorectal cancers can skip surgery after a strong response to immunotherapy.
-
Evaluating biomarkers for immunotherapy resistance in metastatic colorectal cancer
This study is trying to find out which patients with advanced colorectal cancer might not respond to a specific immunotherapy treatment called pembrolizumab, to help doctors choose the best options for their care.
-
Testing NEO212 for treating certain brain tumors and metastases
This study is testing a new treatment called NEO212 for people with certain types of brain tumors to see if it is safe and effective when combined with standard treatments.
-
FOG-001 treatment for advanced or metastatic solid tumors
This study is testing a new drug called FOG-001 to see if it can help people with advanced solid tumors, especially those with certain genetic changes, when traditional treatments aren't working.
Related topics
Quick answers
How many Microsatellite Instability-High Colorectal Cancer clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (2 trials), France (1 trial), Australia (1 trial), Switzerland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.